Modulation of schistosome development by T cell signals
Modulation of schistosome development by T cell signals
批准号:
7568177
负责人:
Stephen J Davies
金额:
$36.08万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2011-02-28
关键词:
AccountingAddressAffectAfricaAnimalsAntigensAreaAsiaBacteriaBiologicalBiological ModelsCD4 Positive T LymphocytesCell CommunicationCell SurvivalCell physiologyCellsComplexCoupledDataDevelopmentDiseaseFoundationsGenomeGoalsHelminthsHumanHuman ResourcesIL2RA geneImmunityImmunocompetentImmunodeficient MouseImmunotherapyInfectionInfection preventionIntegration Host FactorsInterleukin-2IntestinesLaboratory StudyLifeLife Cycle StagesLiverMediatingModelingMolecularMorbidity - disease rateMusOutcomeParasitesParasitic DiseasesPathologyPeace CorpsPeptidesPlasticsPlayPopulationProcessProgram DevelopmentPublic HealthReproductionResearch PersonnelResistance developmentRoleSchistosomaSchistosoma mansonii infectionSchistosomatidaeSchistosomiasisServicesSignal TransductionSouth AmericaSpecificityStagingSystemT-Cell DevelopmentT-LymphocyteTestingTherapeuticTissuesTransgenic MiceUrinary systemVaccinesVirusVisitbasecytokinedevelopmental plasticityin vivoin vivo Modelmigrationmortalitymouse modelnovel strategiespathogenpreventprogramsprophylacticreconstitutionresponsetransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Schistosomiasis, the parasitic disease caused by blood flukes of the genus Schistosoma, causes potentially
serious liver, intestine and urinary system pathology in approximately 200 million people worldwide, resulting
in significant morbidity and mortality. In addition to constituting a major public health concern for people living
in endemic areas in South America, Africa and Asia, schistosomiasis is also a significant concern for U.S.
service personnel, Peace Corps workers and civilians visiting regions where blood flukes are prevalent. High
re-infection rates following treatment and the potential for development of resistance to the few effective
chemotherapeutics for schistosomiasis has prompted efforts to develop vaccines that prevent infection
and/or disease. While an effective vaccine has not yet been developed, evidence from field and laboratory
studies indicate that CD4+ T cell responses will be critical components of the response induced by an
effective vaccine. However, our studies using a murine model of schistosome infection have demonstrated
that, paradoxically, schistosomes also require signals from host CD4+ T cells to complete their development
normally, suggesting that blocking interactions between parasite and host T cells might provide a novel
approach to interfering with parasite development.
The long-term objective of our studies is to contribute to the development of new immunotherapies aimed
at preventing schistosome development in the definitive human host, thus simultaneously preventing the
pathology associated with schistosome infection and blocking parasite transmission. The overall aim of
this study is to further our understanding of the role CD4+ T cells play in facilitating the development and
reproduction of Schistosoma blood flukes. The specific aims of this study are (1) to determine whether the
presence of CD4* T cells alone is sufficient to facilitate parasite development, (2) to determine whether CD4+
T cell responses to schistosome antigens are important in influencing the outcome of schistosome
development, and (3) determine the role of the CD4+ T cell cytokine interleukin-2 (IL-2) in affecting the
outcome of schistosome development. Specific aim 1 will be accomplished by examining schistosome
infections in a transgenic mouse model where none of the animal's CD4+ T cells are able to respond to
schistosome antigens because of their restricted specificity for an unrelated antigen. Specific aim 2 will be
accomplished by selectively reconstituting immunodeficient mice with CD4+ T cells that can or cannot
respond to schistosome antigens prior to infection and then examining the effect of activation with the
appropriate antigen on parasite development. Specific aim 3 will be addressed by examining schistosome
infection in IL-2-deficient mice.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Regulation of innate responses during pre-patent schistosome infection provides an immune environment permissive for parasite development.
潜伏期血吸虫感染过程中对先天反应的调节为寄生虫的发育提供了一个允许的免疫环境。
DOI:
10.1371/journal.ppat.1003708
发表时间:
2013
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Riner DK, Ferragine CE, Maynard SK, Davies SJ]
通讯作者:
Davies SJ
Role of a schistosome cysteine protease in Th response polarization
-
批准号:8444920
-
项目类别:
-
资助金额:$18.01万
-
财政年份:2013
-
负责人:Stephen J Davies
-
依托单位:
Role of a schistosome cysteine protease in Th response polarization
-
批准号:8721840
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2013
-
负责人:Stephen J Davies
-
依托单位:
Modulation of schistosome development by T cell signals
-
批准号:7102526
-
项目类别:
-
资助金额:$36.28万
-
财政年份:2006
-
负责人:Stephen J Davies
-
依托单位:
Modulation of schistosome development by T cell signals
-
批准号:7179334
-
项目类别:
-
资助金额:$36.78万
-
财政年份:2006
-
负责人:Stephen J Davies
-
依托单位:
Modulation of schistosome development by T cell signals
-
批准号:7367900
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2006
-
负责人:Stephen J Davies
-
依托单位:
Immune modualtion of schistosome development
-
批准号:6556802
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2004
-
负责人:Stephen J Davies
-
依托单位:
Immune modualtion of schistosome development
-
批准号:6919866
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2004
-
负责人:Stephen J Davies
-
依托单位:
ADAPTIVE IMMUNITY SUPPORTS SCHISTOSOME DEVELOPMENT
-
批准号:6510193
-
项目类别:
-
资助金额:$5.44万
-
财政年份:2002
-
负责人:Stephen J Davies
-
依托单位:
ADAPTIVE IMMUNITY SUPPORTS SCHISTOSOME DEVELOPMENT
-
批准号:6362261
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2001
-
负责人:Stephen J Davies
-
依托单位:
ADAPTIVE IMMUNITY SUPPORTS SCHISTOSOME DEVELOPMENT
-
批准号:6054625
-
项目类别:
-
资助金额:$4.43万
-
财政年份:2000
-
负责人:Stephen J Davies
-
依托单位:
海外基金